News
-
-
-
-
-
PRESS RELEASE
A new milestone towards the market launch of AXPERA: EU Member States unanimously vote in favour of the approval of Amoéba's biocontrol active substance
Amoéba receives unanimous approval from EU Member States for low-risk biocontrol substance based on amoebae lysate, a milestone for AXPERA solution market launch in Europe from 2026 -
-
PRESS RELEASE
2CRSi SA: 2CRSi anticipates revenue in excess of €200 million by the end of June 2025
2CRSi anticipates revenue forecast exceeding €200 million by June 2025, showcasing strength in strategy, innovation, and global expansion. CEO Alain Wilmouth expresses commitment to sustainable technology and growth -
-
-